HeartSciences Inc (HSCS)

Name: HeartSciences Inc Financial Statements
Creator: Quarter Results

Healthcare | Medical Devices

Latest reporting period: 2026-01-31

Latest Quarter

2026-01-31

Revenue

$0.0

Net Income

-$2.0M

Operating Margin

N/A

Free Cash Flow

-$7.4M

Debt / Assets

95.1%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for HeartSciences Inc (HSCS).
Income Statement (Quarterly)	2026-01-31	2025-10-31	2025-07-31	2025-01-31
Revenue	0	2,419	1,900	0
Cost of Revenue	33,238	33,443	760	0
Gross Profit	-33,238	-31,024	1,140	0
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	1,290,365,000	1,315,353	878,053	1,338,354,000
Operating Expenses	1,895,702	2,042,379	1,875,259	2,371,472,000
Operating Income	-1,928,940	-2,073,403	-1,874,119	-2,371,472,000
Interest Expense	61,509	279,534	183,688	-179,477,000
Income Before Tax	-1,985,208	-2,350,769	-2,054,994	-2,536,292,000
Income Tax Expense	0	0	0	0
Net Income	-1,985,208	-2,350,769	-2,054,994	-2,536,292,000
Per Share
EPS	-0.63	-0.85	-1.58	-2,572.16
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for HeartSciences Inc (HSCS).
Income Statement (Annual)	2025-04-30	2024-04-30	2023-04-30	2022-04-30	2021-04-30
Revenue	4,350	18,600	5,150	14,373	25,604
Cost of Revenue	129,836	6,081	2,796	7,890	10,665
Gross Profit	-125,485	12,519	2,354	6,483	14,939
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	3,840,980	3,439,735	3,654,450	1,714,350	874,620
Operating Expenses	8,227,085	6,318,289	6,115,318	4,715,882	2,583,067
Operating Income	-8,352,571	-6,305,770	-6,112,964	-4,709,399	-2,566,465
Interest Expense	500,453	354,080	243,174	371,619	132,454
Income Before Tax	-8,765,229	-6,605,208	-6,354,290	-4,828,260	-2,452,170
Income Tax Expense	0	0	484,500,000	-250,200	0
Net Income	-8,765,229	-6,605,208	-490,854,290	-4,578,060	-2,452,170
Per Share
EPS	-9.34	-18.74	-6,173.88	-0.02	-0.30
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for HeartSciences Inc (HSCS).
Balance Sheet (Quarterly)	2025-04-30	2024-04-30	2023-04-30	2022-04-30
Assets
Cash and Cash Equivalents	1,098,098	5,807,648	1,660,467	918,260
Short Term Investments	0	0	0	0
Net Receivables	4,350	0	319,381	2,321
Inventory	650,267	629,179	676,359	674,139
Total Current Assets	2,171,457	7,353,893	2,696,581	1,930,877
Property Plant Equipment	435,175	559,974	590,652	158,570
Goodwill and Intangibles	1,616,277	1,589,246	0	0
Total Assets	4,222,909	9,503,113	3,287,233	2,089,447
Liabilities
Account Payables	318,661	448,183	631,369	694,745
Short Term Debt	2,670,688	602,293	529,535	1,720,968
Total Current Liabilities	3,703,211	1,751,767	1,832,891	3,470,569
Long Term Debt	314,527	434,045	1,036,335	4,441,807
Total Liabilities	4,017,738	2,185,812	3,056,676	8,145,244
Shareholders Equity
Retained Earnings	-76,127,635	-67,362,406	-60,757,198	-54,402,908
Total Shareholders Equity	205,171	7,317,301	230,557	-6,055,797

Balance sheet annual history for HeartSciences Inc (HSCS).
Balance Sheet (Annual)	2025-04-30	2024-04-30	2023-04-30	2022-04-30	2021-04-30
Assets
Cash and Cash Equivalents	1,098,098	5,807,648	1,660,467	918,260	723,481
Short Term Investments	0	0	0	0	0
Net Receivables	4,350	0	319,381	2,321	0
Inventory	650,267	629,179	676,359	674,139	750,774
Total Current Assets	2,171,457	7,353,893	2,696,581	1,930,877	1,638,042
Property Plant Equipment	435,175	559,974	590,652	158,570	289,329
Goodwill and Intangibles	1,616,277	1,589,246	0	0	0
Total Assets	4,222,909	9,503,113	3,287,233	2,089,447	1,927,371
Liabilities
Account Payables	318,661	448,183	631,369	694,745	335,781
Short Term Debt	2,670,688	602,293	529,535	1,720,968	487,832
Total Current Liabilities	3,703,211	1,751,767	1,832,891	3,470,569	1,245,994
Long Term Debt	314,527	434,045	1,036,335	4,441,807	2,590,967
Total Liabilities	4,017,738	2,185,812	3,056,676	8,145,244	3,836,961
Shareholders Equity
Retained Earnings	-76,127,635	-67,362,406	-60,757,198	-54,402,908	-49,574,648
Total Shareholders Equity	205,171	7,317,301	230,557	-6,055,797	-1,909,590

Cash flow quarterly history for HeartSciences Inc (HSCS).
Cash Flow Statement (Quarterly)	2025-04-30	2024-04-30	2023-04-30	2022-04-30
Operating Activities
Net Income	-8,765,229	-6,605,208	-6,354,290	-4,828,260
Depreciation & Amortization	127,956	95,133	26,915	26,566
Stock Based Compensation	249,884	405,025	248,308	68,396
Change in Working Capital	517,888	-504,363	173,983	1,124,745
Operating Cash Flow	-7,412,994	-6,070,185	-5,773,577	-3,644,144
Investing Activities
Capital Expenditure	-30,188	-125,271	-18,308	-1,932
Investments	-3,157	-64,455	-18,308	-1,932
Investing Cash Flow	-30,188	-125,271	-18,308	-1,932
Financing Activities
Debt Repayment	1,586,054	42,624	-398,260	-500,000
Common Stock Issued/Repurchased	1,147,578	10,300,013	5,624,065	555,767,000
Dividends Paid	0	0	0	0
Financing Cash Flow	2,733,632	10,342,637	6,534,092	3,840,855
Summary
Free Cash Flow	-7,443,182	-6,195,456	-5,791,885	-3,646,076
Net Change in Cash	-4,709,550	4,147,181	742,207	194,779

Cash flow annual history for HeartSciences Inc (HSCS).
Cash Flow Statement (Annual)	2025-04-30	2024-04-30	2023-04-30	2022-04-30	2021-04-30
Operating Activities
Net Income	-8,765,229	-6,605,208	-6,354,290	-4,828,260	-2,452,170
Depreciation & Amortization	127,956	95,133	26,915	26,566	33,611
Stock Based Compensation	249,884	405,025	248,308	68,396	24,675
Change in Working Capital	517,888	-504,363	173,983	1,124,745	190,127
Operating Cash Flow	-7,412,994	-6,070,185	-5,773,577	-3,644,144	-2,452,294
Investing Activities
Capital Expenditure	-30,188	-125,271	-18,308	-1,932	-712
Investments	-3,157	-64,455	-18,308	-1,932	-712
Investing Cash Flow	-30,188	-125,271	-18,308	-1,932	-712
Financing Activities
Debt Repayment	1,586,054	42,624	-398,260	-500,000	0
Common Stock Issued/Repurchased	1,147,578	10,300,013	5,624,065	555,767,000	0
Dividends Paid	0	0	0	0	0
Financing Cash Flow	2,733,632	10,342,637	6,534,092	3,840,855	2,679,634
Summary
Free Cash Flow	-7,443,182	-6,195,456	-5,791,885	-3,646,076	-2,453,006
Net Change in Cash	-4,709,550	4,147,181	742,207	194,779	226,628